Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Immunochemistry of lysosomal storage disorders|
|Citation:||Clinical Chemistry, 2006; 52(9):1660-1668|
|Publisher:||Amer Assoc Clinical Chemistry|
|Abstract:||<h4>Background</h4>Lysosomal storage disorders are a group of genetic diseases, each with a broad spectrum of clinical presentation that ranges from attenuated to severe. The immunochemical analysis of patient samples is aimed at several key aspects of patient management, including early detection of the disorder, prediction of clinical severity, determining the most appropriate therapeutic regimen, and monitoring of patients on therapy.<h4>Methods</h4>In this study, we review the current and emerging technology available to achieve these assessments.<h4>Results</h4>Immune assays have direct practical application for the early detection, diagnosis and prognosis of lysosomal storage disorder patients. Multiplexing of these assays may provide a platform to allow newborn screening for multiple lysosomal storage disorders.<h4>Conclusions</h4>We have reviewed the immunochemical techniques available for the analysis of lysosomal storage disorder patient samples and advise that these may be used in conjunction with other technologies for effective patient management.|
|Keywords:||Humans; Lysosomal Storage Diseases; Neonatal Screening; Immunologic Tests; Severity of Illness Index; Phenotype; Infant, Newborn; Biomarkers|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.